RNS Number : 3722E Renalytix PLC 07 July 2021 Renalytix plc (" Renalytix " or the " Company ") Exercise of options, PDMR transaction and TVR NEW YORK , 7 July, 2021 - The Board of Renalytix plc (LSE: RENX) announces that it has issued and allotted 27,500 ordinary shares of 0.25 pence
RNS Number : 9118D Renalytix PLC 01 July 2021 Renalytix plc (" Renalytix " or the " Company ") Death of Director NEW YORK , 1 July, 2021 - The Board of Renalytix plc (LSE: RENX) (NASDAQ: RNLX) is saddened to announce the death of Dr. Barbara Murphy , Non-Executive Director and
RNS Number : 7147D Renalytix PLC 01 July 2021 Renalytix plc (" Renalytix " or the " Company ") Total voting rights The Company's total issued share capital consists of 72,197,286 shares of 0.25 pence each, with each share carrying the right to one vote.
RNS Number : 3397D Renalytix PLC 28 June 2021 Renalytix plc ("Renalytix" or the "Company") Director/PDMR Dealing The Company had been informed today that Christopher Mills , a non-executive director and interim Chairman, completed the sale of 6,100 ordinary shares of 0.25 pence each
RNS Number : 2844D Renalytix PLC 28 June 2021 Renalytix plc (" Renalytix " or the " Company ") KidneyIntelX TM Enables Monitoring of SGLT2 Inhibitor Therapy Response and Corresponding Risk Reduction Over Time Study Results lay foundation for KidneyIntelX repeat testing, reimbursement, and
RNS Number : 2249D Renalytix PLC 25 June 2021 Renalytix plc ("Renalytix" or the "Company") Director/PDMR Dealing The Company was informed that today, Fergus Fleming , Chief Technology Officer, completed the sale of 15,000 ordinary shares of 0.25 pence each ("Ordinary Shares") in the
RNS Number : 1945D Renalytix PLC 25 June 2021 Renalytix plc (" Renalytix " or the " Company ") Exercise of options and total voting rights NEW YORK , June 25, 2021 - Renalytix plc (LSE: RENX) (NASDAQ: RNLX) announces that it has issued and allotted 150,000 ordinary shares of 0.25 pence
RNS Number : 0409D Renalytix AI PLC 24 June 2021 Renalytix AI plc (" Renalytix " or the " Company ") Change of name to Renalytix Plc Change of registered office Change of website NEW YORK , June 24, 2021 - Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX) announces it has changed its name to
RNS Number : 7366C Renalytix AI PLC 22 June 2021 The following amendment(s) has been made to the ' Director/PDMR Dealing ' announcement released on 22 June 2021 at 10:57 under RNS No 7062C. The price of 113.5 pence per share was incorrect and has been amended to 1135 pence per share.
RNS Number : 7062C Renalytix AI PLC 22 June 2021 Renalytix AI plc ("Renalytix" or the "Company") Director/PDMR Dealing The Company was informed that today, Christopher Mills , a non-executive director and interim Chairman, completed the sale of 17,000 ordinary shares of 0.25 pence each
